CCNU nephrotoxicity following sustained remission in oat cell carcinoma
Silver, H.K.; Morton, D.L.
Cancer Treatment Reports 63(2): 226-227
1979
ISSN/ISBN: 0361-5960 PMID: 221116 Document Number: 153701
Document emailed within 1 workday
Related Documents
Celik, I.; Erman, M.; Kars, A.; Tekuzman, G. 1998: The efficacy of CCNU in non-small cell lung carcinoma presenting with cranial metastases Journal of Experimental and Clinical Cancer Research: Cr 17(3): 375Edmonson, J.H.; Lagakos, S.; Stolbach, L.; Perlia, C.P.; Bennett, J.M.; Mansour, E.G.; Horton, J.; Regelson, W.; Cummings, F.J.; Israel, L.; Brodsky, I.; Shnider, B.I.; Creech, R.; Carbone, P.P. 1976: Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung Cancer Treatment Reports 60(5): 625-627
Bernath, A.M.; Cohen, M.H.; Ihde, D.C.; Fossieck, B.E.; Matthews, M.J.; Minna, J.D. 1976: Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung Cancer Treatment Reports 60(9): 1393-1394
Aroney, R.S.; Aisner, J.; Wesley, M.N.; Whitacre, M.Y.; Van Echo, D.A.; Slawson, R.G.; Wiernik, P.H. 1983: Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma Cancer Treatment Reports 67(7-8): 675-682
Omura, G.A.; Shingleton, H.M.; Creasman, W.T.; Blessing, J.A.; Boronow, R.C. 1978: Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva Cancer Treatment Reports 62(5): 833-835
Lachiewicz, M.P.; Khanna, N.; Gordon, A.N.; Horowitz, I.R. 2017: Long-term remission of clear cell carcinoma of the cervix after chemoradiation with 109 cycles of paclitaxel: a case report and literature review European Journal of Gynaecological Oncology 38(3): 456-458
Raghavan, K.S.; Shek, E.; Bodor, N. 1987: Improved delivery through biological membranes. XXX. Synthesis and biological aspects of a 1,4-dihydropyridine based chemical delivery system for brain-sustained delivery of hydroxy CCNU Anti-Cancer Drug Design 2(1): 25-36
Rossi, A.; Riva, A.; Bonadonna, G. 1975: Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer Cancer ChemoTherapy Reports 59(6): 1161-1162
Sonntag, R.W.; Brunner, K.W.; Batz, K.; Ryssel, H.J. 1975: Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037) Cancer ChemoTherapy Reports 59(2 Part 1): 429-431
de Graeff, A.; de Groot, J.A.; Schornagel, J.H. 1987: Chemotherapy with doxorubicin and CCNU in advanced undifferentiated carcinoma of the nasopharynx. A retrospective report on five patients Netherlands Journal of Medicine 31(3-4): 111-116
Kumar, S.; Kokate, R.A.; Sahu, M.; Chaudhary, P.; Sharma, R.; Awasthi, S.; Awasthi, Y.C. 2011: Inhibition of mercapturic acid pathway-mediated disposal of 4-hydroxynonenal causes complete and sustained remission of human cancer xenografts in nude mice Indian Journal of Experimental Biology 49(11): 817-825
Samson, M.K.; Baker, L.H.; Fraile, R.J.; Izbicki, R.M.; Vaitkevicius, V.K. 1977: Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients Cancer Treatment Reports 61(1): 59-64
Izumi, T. 1988: Experimental studies on the nephrotoxicity of cisplatin--amelioration of nephrotoxicity by continuous infusion Hinyokika Kiyo. Acta Urologica Japonica 34(1): 37-45
Kojima, R.; Suzuki, Y. 1984: Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects. (2). Protective effect of latamoxef against gentamicin nephrotoxicity Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(5): 463-469
2007: E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission Clinical Advances in Hematology and Oncology: H&o 5(1): 13-14
Ben-Nun, A.; Cohen, I.R. 1982: Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines Journal of Immunology 128(3): 1450-1457
Papajik, T.; Raida, L.; Faber, E.; Vondrakova, J.; Prochazka, V.; Kubova, Z.; Skoumalova, I.; Jarosova, M.; M, L.K.; Paucek, B.; Myslivecek, M.; Neoral, C.; Oral, I.; Jarkovsky, J.; Dusek, L.; Indrak, K. 2008: High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission Neoplasma 55(3): 215-221
Shih, W.W.; Baumhefner, R.W.; Tourtellotte, W.W.; Haskell, C.M.; Korn, E.L.; Fahey, J.L. 1983: Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis Clinical and Experimental Immunology 53(1): 122-132
Bertrand, H.; Doucet, F.; Cornudet, B.; Lebreton, M.; Garrigue, G. 1980: Papilloma of the larynx: carcinoma, recurrence, spontaneous remission Journal Francais d'Oto-Rhino-Laryngologie; Audiophonologie Chirurgie Maxillo-Faciale 29(5): 333-334
Rezk, G.; Yatto, R.P.; Friscia, P. 1981: Metastatic bronchogenic carcinoma; endoscopically proved remission New York State Journal of Medicine 81(12): 1783-1785